Search Results for: crispr

Horwitz Interview Zooms in on Allen Cell Institute: the GoogleMaps of Cells

Rick-Horwitz

One of the most exciting developments in the biomedical sciences in 2014 was the announcement of the new Allen Institute for Cell Science. This new institute, which will be focused on cell biology, received $100 million in funding from high-tech pioneer and philanthropist, Paul Allen. I am very curious about how the institute will tackle cell […]

Horwitz Interview Zooms in on Allen Cell Institute: the GoogleMaps of Cells Read More »

About Us, The Niche and Knoepfler Lab

Knoepfler-Lab-2019

The Niche is the top, most authoritative stem cell and regenerative medicine blog on the web. It’s the only one to our knowledge written mostly by a professor. Professor Paul Knoepfler of UC Davis School of Medicine, an internationally respected stem cell biologist and educator, runs The Niche. Knoepfler is an advocate of rigorous evidence-based

About Us, The Niche and Knoepfler Lab Read More »

Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient

viacyte-encaptra

Chalk up another exciting development for the stem cell and regenerative medicine field in 2014 related to diabetes. It’s been a huge year. (Update: read my Fall 2019 interview with ViaCyte here.) For the first time ever, an ES cell-based device has been transplanted into a diabetic patient. ViaCyte working together with Dr. Robert Henry

Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient Read More »

Challenge tries to cancel Yamanaka iPS cell patent

Patent-challenge

A new patent dispute has exploded in the stem cell field related to induced pluripotent stem (iPS) cells. What’s going on? In 2006, Shinya Yamanaka reported cellular reprogramming to create mouse induced pluripotent stem (iPS) cells in Cell and the next year multiple groups along with Yamanaka’s reported creating human iPS cells. It’s no exaggeration

Challenge tries to cancel Yamanaka iPS cell patent Read More »

Knoepfler Lab

The Knoepfler Lab conducts stem and cancer cell as well as chromatin/epigenetics research at the UC Davis School of Medicine. Our team has two big picture goals: (1) catalyzing the development of more effective treatments for cancers based on targeting stem cell-related machinery in tumorigenesis and (2) producing safer stem cell-based regenerative medicine therapies. We are particularly

Knoepfler Lab Read More »

Histone H3.3: giving cells epigenetic flexibility

chromosomal bridge in histone H3.3 knockout

A relatively newly recognized, important player in the stem cell field is a molecule called histone H3.3. Histones are key components of chromatin with integral roles in regulating almost all aspects of cell behavior through orchestrating functions such as transcription and chromosome segregation. Histone H3.3 knockout My lab has just (April 9) published new studies

Histone H3.3: giving cells epigenetic flexibility Read More »

Wilmut voted most-deserving of 3rd Nobel slot with Yamanka & Gurdon in poll

Poll-results-Nobel

I have a poll running regarding who would have been the best choice to share the Nobel Prize with Shinya Yamanaka and John Gurdon, and so far the winner is Ian Wilmut, who cloned the first mammal, Dolly the sheep. I should have included another option to indicate the possible preference that NO ONE should

Wilmut voted most-deserving of 3rd Nobel slot with Yamanka & Gurdon in poll Read More »